Evidence map›Paper›PMID 42143096›Full record

ArticleNature communications2026

GPCR kinases shape ACKR4 functions via differential C-terminal phosphorylation.

Oliver J Gerken, Rebecca Warmers, Clara Hild, Niklas Kielkopf, Nicola Catone, Roland Bruderer, Daniel F Legler

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oliver J GerkenInstitute of Cell Biology and Immunology Thurgau (BITG) at the University of Konstanz, University of Konstanz, Kreuzlingen, Switzerland.ORCID http://orcid.org/0009-0006-8208-4528
Rebecca WarmersInstitute of Cell Biology and Immunology Thurgau (BITG) at the University of Konstanz, University of Konstanz, Kreuzlingen, Switzerland.
Clara HildInstitute of Cell Biology and Immunology Thurgau (BITG) at the University of Konstanz, University of Konstanz, Kreuzlingen, Switzerland.
Niklas KielkopfInstitute of Cell Biology and Immunology Thurgau (BITG) at the University of Konstanz, University of Konstanz, Kreuzlingen, Switzerland.ORCID http://orcid.org/0009-0009-6927-699X
Nicola CatoneInstitute of Cell Biology and Immunology Thurgau (BITG) at the University of Konstanz, University of Konstanz, Kreuzlingen, Switzerland.
Roland BrudererBiognosys AG, Schlieren, Switzerland.ORCID http://orcid.org/0000-0002-1049-5524
Daniel F LeglerInstitute of Cell Biology and Immunology Thurgau (BITG) at the University of Konstanz, University of Konstanz, Kreuzlingen, Switzerland. daniel.legler@bitg.ch.ORCID http://orcid.org/0000-0001-8610-4764

Funding

Federal Department of Economic Affairs, Education and Research, Switzerland | Staatssekretariat für Bildung, Forschung und Innovation (State Secretariat for Education, Research and Innovation) BITGSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 220358
6 · The paper itself

Abstract

Atypical chemokine receptor 4 (ACKR4) is a scavenger receptor that regulates the availability of chemokines, including CCL19, and consequently the responsiveness of their classical G protein coupled receptors (GPCRs). In contrast to classical chemokine receptors, ACKR4 is completely biased towards βarrestins and does not couple to G proteins. Here, we show that ACKR4 in its apo state constitutively pre-associates with βarrestins and cycles between the plasma membrane and endosomal compartments. We identify distinct serine and threonine residues in the tail region of ACKR4 involved in regulating steady-state receptor trafficking and chemokine uptake, and that a C-terminal serine/threonine cluster is key for both ligand-mediated βarrestin recruitment and efficient chemokine uptake. Moreover, different serine/threonine clusters in the tail region of ACKR4 account for steady-state and chemokine-driven association of the four non-visual GPCR kinases (GRKs), which differentially phosphorylate two serine and one threonine residues. We show that GRK5/6 primarily phosphorylate ACKR4 in the absence of chemokines, and that CCL19 stimulation recruits GRK2/3 to enhance ACKR4 phosphorylation. Notably, we found that apo ACKR4 forms a ternary complex with GRK2/3 and the G protein without activating it. Finally, we show that the C-terminal serine/threonine cluster of ACKR4 and GRK2 play leading roles in βarrestin recruitment and CCL19 internalisation.

Indexed as

G-Protein-Coupled Receptor KinasesReceptors, CCRAnimalsbeta-ArrestinsCell MembraneEndosomesG-Protein-Coupled Receptor Kinase 5HEK293 CellsHumansPhosphorylationProtein TransportSerineThreoninebeta-ArrestinsG-Protein-Coupled Receptor Kinase 5G-protein-coupled receptor kinase 6G-Protein-Coupled Receptor KinasesReceptors, CCRSerineThreonine

Identifiers

PMID42143096
PMCPMC13377056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.